Cell Cycle / Checkpoint Control

The Fos family of nuclear oncogenes includes c-Fos, FosB, Fos-related antigen 1 (FRA1) and Fos-related antigen 2 (FRA2) (1). While most Fos proteins exist as a single isoform, the FosB protein exists as two isoforms: full-length FosB and a shorter form FosB2 (ΔFosB) that lacks the carboxy-terminal 101 amino acids (1-3). The expression of Fos proteins is rapidly and transiently induced by a variety of extracellular stimuli, including growth factors, cytokines, neurotransmitters, polypeptide hormones and stress. Fos proteins dimerize with Jun proteins (c-Jun, JunB and JunD) to form Activator Protein-1 (AP-1), a transcription factor that binds to TRE/AP-1 elements and activates transcription. Fos and Jun proteins contain the leucine-zipper motif that mediates dimerization and an adjacent basic domain that binds to DNA. The various Fos/Jun heterodimers differ in their ability to transactivate AP-1 dependent genes. In addition to increased expression, phosphorylation of Fos proteins by ERK kinases in response to extracellular stimuli may further increase transcriptional activity (4-6). Phosphorylation of c-Fos on serine 32 and threonine 232 by Erk5 increases protein stability and nuclear localization (5). Phosphorylation of FRA1 on serines 252 and 265 by Erk1/2 increases protein stability and leads to over-expression of FRA1 in cancer cells (6). Expression of FosB and c-Fos in quiescent fibroblasts after growth factor stimulation is immediate, but very short-lived, with protein levels dissipating after several hours (7). However, FRA1 and FRA2 expression persists longer and appreciable levels can be detected in asynchronously growing cells (8). Deregulated expression of c-Fos, FosB, or FRA2 can result in neoplastic cellular transformation; however, FosB2 lacks the ability to transform cells (2,3).

1. Tulchinsky, E. (2000) Histol. Histopathol. 15, 921-928.
2. Dobrzanski, P. et al. (1991) Mol. Cell. Biol. 11, 5470-5478.
3. Nakabeppu, Y. and Nathans, D. (1991) Cell 64, 751-759.
4. Rosenberger, S.F. et al. (1999) J. Biol. Chem. 274, 1124-1130.
5. Sasaki, T. et al. (2006) Mol. Cell 24, 63-75.
6. Basbous, J. et al. (2007) Mol. Cell. Biol. 27, 3936-3950.
7. Kovary, K. and Bravo, R. (1991) Mol. Cell. Biol. 11, 2451-2459.
8. Kovary, K. and Bravo, R. (1992) Mol. Cell. Biol. 12, 5015-5023

本製品は試験研究用です。

FosB Blocking Peptide

©1999-2010 Cell Signaling Technology, Inc.

問合せ

FosB Blocking PeptideのCSTジャパン